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Histone lysine methyltransferases (HKMTs), catalyze mono-, di- and trimethylation of lysine residues, resulting in a
regulatory pattern that controls gene expression. Their involvement in many different cellular processes and
diseases makes HKMTs an intensively studied protein group, but scientific interest so far has been concentrated
mostly on their catalytic domains. In this work we set out to analyze the structural heterogeneity of human HKMTs
and found that many contain long intrinsically disordered regions (IDRs) that are conserved through vertebrate
species. Our predictions show that these IDRs contain several linear motifs and conserved putative binding sites
that harbor cancer-related SNPs. Although there are only limited data available in the literature, some of the
predicted binding regions overlap with interacting segments identified experimentally. The importance of a
disordered binding site is illustrated through the example of the ternary complex between MLL1, menin and
LEDGF/p75. Our suggestion is that intrinsic protein disorder plays an as yet unrecognized role in epigenetic
regulation, which needs to be further elucidated through structural and functional studies aimed specifically at the
disordered regions of HKMTs.
Reviewers: This article was reviewed by Arne Elofsson and Piotr Zielenkiewicz.
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The complex pattern of posttranslational modifications
(PTMs) of histone proteins result in an epigenetic regu-
latory code that controls entire gene expression pro-
grams within a cell [1]. One of the best characterized
histone modifications is methylation, that can occur on
lysine or arginine residues [2]. Lysine methylation is me-
diated by histone lysine methyltransferases (HKMTs), a
protein family defined by the presence of the SET do-
main, named after the Drosophila proteins Suppressor of
variegation 3–9 [Su(var)3–9], Enhancer of zeste [E(z)],
and Trithorax (Trx) [2]. DOT1L is the only protein that
is capable of lysine methylation, despite the absence of a
SET domain [3]. Many HKMTs are involved in different
types of cancer [4, 5], making them an intensively stud-
ied protein group. While most studies are directed to
the catalytic domain(s), we aimed at the structural* Correspondence: tantos.agnes@ttk.mta.hu
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domains. After finding that a significant proportion of
the studied sequences are predicted to be intrinsically
disordered, we tried to identify possible functional sites
within these regions.
Intrinsically disordered proteins and protein regions
(IDPs/IDRs) lack stable 3D structure in their functional
state that confers a multitude of functional advantages
[6], utilized in the diverse roles of IDPs in important bio-
logical processes [7, 8].
Although proteins participating in chromatin remodel-
ling are known to have high levels of disorder in general
[9], HKMTs distinguish themselves from other histone
modifying enzymes not only by a high level of disorder
(Additional file 1: Figure S1A), but also by the length of
their disordered regions. Whereas 60 % of HKMTs con-
tain IDRs longer than 80 amino acids (Additional file 1:
Figure S1B), less than 20 % of eukaryotic proteins con-
tain IDRs of similar length [10].
An evolutionary comparative analysis shows that the
average length and number of proteins responsible forle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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sharpest transitions occurring between prokaryotes and
eukaryotes and lower eukaryotes and vertebrates. Al-
though the statistical analysis is hindered by large stand-
ard deviation values and the limited sample size in
certain cases (for example, the histone demethylase
group of protostomes contains only one representative
and there are only two known bacterial histone arginine
methyltransferases), HKMTs are almost always signifi-
cantly longer than other histone modifying enzymes
(Additional file 2: Figure S2). This is not true for pro-
karyotes, where HKMTs constitute the shortest proteins
of the studied groups. This observation also includes
that the length of HKMTs rose more sharply in eukary-
otes than in other histone modifying enzyme families.
Since it was shown earlier that protein length and intrin-
sic protein disorder does not correlate closely with or-
ganism complexity [11], this elevated length is probably
related to the specific function and regulation of the
HKMT proteins rather than being a general evolutionary
trait. Contrary to protein length, the number of HKMT
proteins is generally not significantly higher than other
histone modifying enzymes in the studied evolutionary
groups, although in some specific cases we could detect
significant differences. This finding shows that in case of
HKMTs, more complex regulation with growing organ-
ism complexity was achieved through extending individ-
ual proteins, rather than producing more, specialized
representatives of the family.
In order to determine the evolutionary variability of
these IDRs, we performed disorder conservation analysis
of the mostly disordered HKMTs, using the DisCons [12]
webtool, which can differentiate between constrained and
flexible disorder. Disorder is considered constrained when
disorder tendency and sequence of a region are both con-
served, while flexible disorder means that only the dis-
order tendency is retained through evolution. The analysis
showed that the long IDRs are highly conserved in verte-
brates, with constrained disorder conservation levels
above 80 % for all examples (Additional file 3: Table S1).
Since disordered proteins generally tolerate sequence
changes better than globular proteins [13, 14], the fact that
not only disorder, but also sequences are conserved, shows
that these regions harbor important functional sites.
CREB-binding protein (CBP), a histone acetyltransferase
with experimentally confirmed functions in its disordered
regions [15], has a similar disorder conservation level as
the studied HKMTs.
Although many HKMTs contain single amino acid re-
peat regions (see Additional file 4: Table S2.) and other
low complexity regions (LCRs), SEG analysis [16] shows
that contrary to protein disorder, LCRs are not overrep-
resented in any of the histone modifying protein families
compared to the average of human proteins, and theoverlap between LCRs and IDRs is limited (Additional
file 1: Figure S1C.). This suggests that although LCRs
are thought to be involved in mediating flexible protein-
protein interactions [17], it seems that in this particular
case, low complexity is not a dominant feature.
Polyglutamine sequences are among the most studied
LCRs due to their involvement in many diseases [18]. Of
HKMTs, only MLL4 contains long stretches of polyglu-
tamine (polyQ) repeats (14 regions with lengths between
5 and 13 amino acids). A long run of glutamines be-
tween aa 3898 and 3974 is also found in MLL4, where Q
repeats are interrupted with a leucine residue at every
five to ten residues. This region is predicted to form a
coiled-coil structure [19] and may be involved in stabil-
izing protein-protein interactions as suggested for such
regions by Schaefer et al. [20]. It is to be noted that
LCRs also often have highly repetitive Q/N-rich regions,
which may undergo regulated structural transitions from
a disordered to a highly ordered amyloid-like state, con-
ferring prion-like functions on the protein [21].
The main functional regions of IDPs/IDRs, however, are
short recognition elements, most often termed eukaryotic
linear motifs (ELMs). A search in the ELM database [22]
for known sequence motifs in the disordered regions of
HKMTs resulted in a limited number of annotated motifs,
but we could identify more ELM hits with the database’s
acceptable expectation value. One of the most frequent
motifs found was LIG_WD40_WDR5_WIN_1 which is
responsible for binding WDR5 and WD40 domains [23].
Other motifs with reliable e-values are involved in
transcriptional activation/repression, cellular prolifera-
tion, ubiquitination, DNA repair, RNA binding and spli-
cing. These are in good correlation with the functions
generally assigned to HKMTs [2], but the physiological
role of these predicted motifs remains to be experimen-
tally validated. We found 18 different motifs altogether,
and these occurred at 50 different sites in the mostly dis-
ordered HKMTs (Additional file 4: Table S2). This repre-
sents more than 2 predicted ELM motifs per 1000
residues, which is significantly higher than the number
obtained for randomized sequences with the same amino
acid composition (0.645 ELM motif per 1000 residues,
p < 0.0001). The average level of conservation of motifs
predicted in MLL1 and MLL4 is significantly higher
(p = 0.001 and p = 0.003, respectively) than that of the
whole proteins, but ELM motifs in the other, highly disor-
dered HKMTs (NSD1, SUV420H1, PRDM2 and DOT1L)
do not show significantly higher conservation. Given
that the average conservation of these proteins is
already rather high, this does not necessarily question
their functional importance. Our suggestion is that
some, or many of the ELMs found in this study may par-
ticipate in the interactions of HKMTs with other macro-
molecules, making them excellent candidates for further
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participating in protein-protein interactions occur at a
significantly (p < 0.0001) higher level in the studied
HKMTs (1.7814 motifs/1000 aa) than in randomized se-
quences (0.995 motifs/1000 aa), underscores this propos-
ition. It is also informative that research directed at the
non-enzymatic regions of HKMTs has already unveiled a
new motif that mediates the interaction of different pro-
teins with LEDGF/p75 [24].Fig. 1 IUPred profile of four representative HKMTs and CBP. Regions with c
predicted binding regions (yellow), known binding regions (orange horizon
1List of PDB structures: MLL1: 4gq6_b, 3u88_m, 2mtn_a, 2msr_a, 2j2s_a, 2k
3ooi_a; DOT1L: 3uvp_a, 2mv7_b; CBP: 1rdt_e, 1lik_a, 2lxt_a, 4n4f_a, 2kje_aUsing the ANCHOR [25] server that can predict disor-
dered binding regions from sequence, we mapped the
potential binding regions of the IDRs of HKMTs. The
number of ANCHOR sites (30.106 regions/1000 aa) is
significantly higher (p < 0.0001) than that found in the
randomized sequences (25.935 regions/1000 aa). In
order to reduce the number of false positive hits, we
only considered the ANCHOR sites that were conserved
in vertebrates (Fig. 1). A comparison with differentorresponding PDB structures (red1), SCOP domains (green), conserved
tal lines) and cancer associated SNPs (black diamonds) are indicated.
yu_a, 3lqh_a, 2agh_c, 2w5y_a; MLL4: 3uvk_b, 3erq_d, 4z4p_a; NSD1:
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in several hits localized to these putative binding regions.
Since HKMTs work mainly as parts of large complexes
[2], it is not unfounded to suggest that these may be the
regions responsible for mediating functionally important
interactions. A recently characterized DOT1L-AF9 inter-
action [26] overlaps with a predicted binding site (Fig. 1),
pointing to the validity of our suggestions. AF9 is a fu-
sion partner of MLL1 and is involved in the leukemias
involving MLL fusions [27], which highlights the import-
ance of DOT1L-AF9 interaction.
The disordered region of DOT1L is probably also in-
volved in the H2BUb-H3K79 crosstalk, since a C-terminal
truncated construct can methylate nucleosomes in the ab-
sence of the facilitating ubiquitin (Ub) mark [28]. Ubiqui-
tin interaction appears to be mediated through lysine-rich
regions in DOT1 proteins, as shown for yeast DOT1P
[29]. The lysine-rich region of yeast DOT1P localizes in
the disordered region of the protein and human DOT1Ll
also contains a disordered lysine-rich region that might be
involved in the H2BUb-H3K79 crosstalk. The lysine-rich
region homologous to that of yeast DOT1P is localized
between amino acids 387–416 in DOT1L, and overlaps
with a conserved ANCHOR site (aa 408–416) according
to our prediction (Fig. 1). The notion that it is a valid and
important interaction site is corroborated by the three
SNPs in this region that are found in cancer databases.
NSD1 also uses a disordered region for interacting
with Nizp1 in mediating gene repression [30]. The inter-
acting region of mouse NSD1 is a cysteine-rich region
(aa 2117–2207) that corresponds to a conserved AN-
CHOR sequence in the human protein (Fig. 1), raising
the possibility of a similar mechanism in human cells.
MLL proteins also contain several conserved ANCHOR
regions, some of them in longer sequences that are known
to participate in structurally not characterized partner
binding (Fig. 1). The reliability of our predictions is sup-
ported by the finding that the ternary complex formed be-
tween the activation domain of MLL1, the KIX domain of
CBP and the TAD of c-Myb [31] is mediated by a short se-
quence in MLL1 between residues 2844 and 2857 [32].
This interaction is essential for transcriptional activation
by MLL [31] and overlaps with one of the conserved AN-
CHOR sites (aa 2841–2853).
The functional importance of regions of MLL proteins
other than their SET domain is underlined by the fact
that unlike mll−/− mice, animals with SET domain-
deleted MLL are viable and fertile, although they show
defects in DNA methylation [33]. The SET domain is
also lost in MLL rearranged leukemias, where the N-
terminal region of MLL proteins is fused to various pro-
tein partners, resulting in aberrant expression of MLL
target genes [34]. The disordered nature of the MLL
protein is important for the fusion proteins to be viablein the cells, as a link between protein disorder and fu-
sion protein survival was shown in a previous work [35].
The extreme length of the IDRs found in HKMTs sug-
gests that these regions have further roles than simply
presenting interaction sites of a couple of amino acids in
length. Involvement of long disordered regions in estab-
lishing long-range contacts between spatially distant
binding partners was suggested for proteins participating
in nonsense-mediated decay [36]. HKMTs might rely on
similar strategies when recognizing other histone modifi-
cations, exemplified by the H2BUb-H3K79 crosstalk in
the case of DOT1L. These long IDRs may also serve as
tools for complex intramolecular regulation through the
interplay of a variety of elements, domains, motifs and
linkers in a phenomenon termed ‘multistery’ [37].
Although disordered regions do not fold into a well-
defined structure on their own, they often gain structure
upon binding to different partners through induced folding
[38]. The ternary complex formed between MLL1, menin
and LEDGF/p75, critical for the development of MLL
leukemia [39], is a good example of a well-characterized
interaction involving disordered regions. We demonstrate
how a disordered segment can change the stability of a
complex through the analysis of the published structures
supplemented with molecular modeling.
The originally published crystal structure (PDB: 3U88)
contained a region spanning amino acids 4 to 153 of
MLL1 from which the disordered segments (aa 16–22
and 36–102) were removed [40]. We performed molecu-
lar dynamics simulations using the sequence of MLL1
between amino acids 1 and 200. Our simulations show
that this region is highly dynamic in the unbound state,
sampling a multitude of different conformations (Fig. 2a),
with short regions of limited preference for secondary
structural elements. The region between amino acids
120–140 has the highest tendency to fold into a continu-
ous alpha helical state which is capable of facilitating
binding (Fig. 2b). The ensuing conformational selection
is a basic mechanism of disordered proteins binding to
their binding partners [38].
A short segment of MLL1 (aa 140–160) binds LEDGF/
p75 independently of the formerly described helix [41,
42] through a region that does not fold upon binding
and has no particular structural propensity in the un-
bound state (PDB: 2MSR, Fig. 2b). This is an example of
the unique ability of IDPs to bind without folding [43],
which is nevertheless very important for the stability of
the ternary complex. Our molecular dynamics simula-
tions demonstrate that the LEDGF/p75-menin complex
is not stable, (Additional file 5: Movie 1) and while the
MLL1 helix between menin and LEDGF/p75 stabilizes
the ternary complex with hydrophobic and electrostatic
interactions (Additional file 6: Movie 2), the extensive
movements of LEDGF/p75 relative to menin might not
Fig. 2 Molecular dynamics simulation of MLL1-menin-LEDGF/p75 complex. a Overlay of 20 structures between 900 k-1100 k steps of DMD of free
MLL1 N-terminus. The region between amino acids 120–135 are highlighted in red or orange. b DSSP helix content of the free MLL1 N-terminus
per frame versus the amino acid chain. Orange to red lines represent the number of replicas (one, two or three) in any given frame that contain
an amino acid in helical conformation (1–2000 k steps). c Structure of the ternary complex as represented in PDB database (3U88). Salmon: MLL1,
cyan: LEDGF/p75, green: menin. Side chains of F148 and F151 in MLL1 are red. Intramolecular contacts are shown as yellow-red dots. d Structure
of the ternary complex as modeled with the disordered regions of MLL1 based on PDB structures 3U88 and 2MSR. Salmon: MLL1, cyan: LEDGF/
p75, green: menin. Side chains of F148 and F151 in MLL1 are red. Intramolecular contacts are shown as yellow-red dots (at 200 k steps)
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the two interacting amino acids of the disordered loop
(F148 and F151) do not form stable bonds with the part-
ners, the simulation containing the loop region showed
a much more stable complex (Additional file 7: Movie
3). The MLL1 construct in the published crystal struc-
ture also contains the binding phenylalanines, but no co-
ordinates could be assigned to them [40], revealing that
they remain disordered even in the confines of a crystal
lattice. This model illustrates nicely that two different
IDR binding strategies (folding upon binding and bind-
ing without folding) can work together to modulate the
stability of a binding interface. The fact that in the case
of the MLL6–153 there could be no interaction detected
with LEDGF/p75 [40] but the region 1–160 interacts
with LEDGF/p75 alone [41, 42], hints at the importance
of amino acids distant to the actual binding site. This
observation underlines that even though many IDP in-
teractions are mediated by residual structural elements,
lack of a tendency to fold does not necessarily mean a
lack of interaction capability and function.
Apart from the known binding regions of MLL1, our
simulations also included a large disordered loop ofMLL1 between amino acids 36 and 102. The larger
number of intramolecular contacts in the model com-
pared with the crystallized complex (68 versus 45, re-
spectively) suggests that disordered regions distant to
the binding site may also contribute to the interaction
(Fig. 2c and d). The loop region does not seem to make
extensive contacts with either partners and might serve
as a platform for other interaction partners.
In all, we have shown that intrinsic disorder is a promin-
ent feature of HKMTs and the intricate regulation and
complex activity of these important enzymes cannot be
fully understood without dissecting the behavior of these
regions. The rare instances where disordered regions of
HKMTs were studied show that many important functions
lie in these sequences. Given the extreme length of IDRs
in some of the HKMTs, it is entirely possible that many
other functions await discovery. For this reason it is im-
portant to direct structural and biochemical studies at the
disordered segments of these proteins. Most promising
candidates would be the conserved ANCHOR regions, es-
pecially those that contain cancer-related SNPs. Regions
participating in detected, but uncharacterized partner
binding also bear the possibility of notable discoveries.
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genetic regulation is important for a deeper understanding
that may bring further development of this field.
Methods
The human histone lysine methyltransferase (HKMT)
dataset was taken from an article published in 2013
about the SET domain containing histone methyltrans-
ferases [2]. DOT1L was added manually as the only
HKMT lacking a SET domain. UniProt Acc-s and infor-
mation about the length of the protein sequences were
collected from the UniProt database.
Histone modifying enzymes were collected from the Uni-
Prot database by searching with the enzyme names and the
appropriate GO annotations: ‘histone-lysine N-methylase
activity’, ‘histone-arginine N-methylase activity’, ‘histone ace-
tyltransferase activity’, ‘histone demethylase activity’ and ‘his-
tone deacetylase activity’. Protein existence was ‘not
uncertain’ and fragment sequences were left out. Of the dif-
ferent variants of the same protein, only the longest version
was used for analysis. The human dataset consisted of 34
HKMTs, 8 HRMTs, 29 HATs, 22 Histone demethylases
and 18 Histone deacetylases. The datasets used for evolu-
tionary analysis contained 2230 HKMTs, 374 HRMTs, 4444
HATs, 539 Histone demethylases and 2038 Histone deace-
tylases. Evolutionary groups were formed and named as fol-
lows: Bacteria, Archea, Eukaryotic unicellular (Eukaryotic
species that are not plants, metazoans or fungi), Fungi,
Metazoa1 (Metazoans except for protostomes and deutero-
stomes, e.g. sponges, cnidarians), Metazoa2 (Protostomes
except for Ecdysozoa, e.g. flatworms, annelids, molluscs),
Metazoa3 (Ecdysozoa), Metazoa4 (Deuterostomes except
for vertebrates), Metazoa5 (Vertebrates). For this analysis
reference proteomes were used only.
Structural disorder was predicted with the IUPred long
disorder predictor [44]. The overall disorder rate was
computed as the fraction of residues with an IUPred
score of at least 0.5. To evaluate the IUPred long dis-
order prediction, we compared its scores to the results
given by nine other disorder predictions from MobiDB
[45]. IUPred gives the same per aa classification as the
consensus in >90 % of the sequences (Average IUPred
disagreement: 9.4 ± 4.7 % st.error).
We searched human linear motifs in the disordered
HKMTs (disorder rate higher than 50 %) in the ELM
database [22], and only collected the ones annotated
from the literature and the hits with e-value < 0.0001,
both with nuclear localization. The construction of
scrambled sequences to check for the significance of the
frequency of ELM hits in HKMTs was made by shuffling
the amino acid residues of the above mentioned HKMTs
having an IUPred score at least 0.5, using a Perl script.
Twenty constructs were generated with length of 10000
residues for a 10x sequence coverage.PDB structures were searched manually, while SCOP
domains were assigned with the help of annotations in
the D2P2 database [46]. Literature mining for known
binding regions of HKMTs was done by reading the evi-
dence references of the interaction hits found in the Bio-
Grid database [47]. Cancer-related single nucleotide
polymorphisms in the long conserved IDR regions were
collected from the BioMuta v2.0 [48] and COSMIC da-
tabases [49]. Long conserved disordered binding regions
were calculated in two steps: first, we predicted longer
(min. 8 residues) disordered binding regions by AN-
CHOR [25]. Next, we took the intersection of the set of
these regions with the Scorecons [50] conservation out-
put (with default valdar01 scoring) defining “con-
strained” regions with a value of at least 0.9, based on a
multiple alignment generated out of 22–24 vertebrate
orthologs. The multiple sequence alignment was gener-
ated in UniProt selecting the “canonical” sequences from
the vertebrate organisms, ignoring fragments, using
BLAST with default parameters (Clustal-Omega align-
ment, Gonnet transition matrix, gap opening penalty 6
bits, gap extension 1 bit). Each vertebrata multiple align-
ment file of the proteins contained a broad range of spe-
cies from primates to the earliest diverged fishes.
The calculation of sequence conservation and disorder
conservation was carried out by DisCons [12], from
alignments with default parameters (IUPred long,
Jensen-Shannon divergence, window size of 3). As input
alignment we used the same vertebrata alignment that
we used in the case of Scorecons [50].
To determine if two normally distributed sets of data
were significantly different from each other, or observed
values were significantly different from a given mean, we
performed two-sample and one-sample t-tests, respect-
ively, using a statistical significance threshold of 0.05 to
reject the null hypothesis.
For the Discrete Molecular Dynamics (DMD) simula-
tions the following input sequences were generated: i) for
the free MLL1 N-terminus, the amino acids 1–200 of
MLL1 (UniProt: Q03164) were used to generate an ex-
tended structure in PyMol (The PyMOL Molecular
Graphics System, Version 1.5.0.1 Schrödinger, LLC); ii) for
menin and LEDGF/p75, sequences provided in PDB entry
3U88 were used, while for MLL1, the disordered regions
removed from the construct were reinserted into the se-
quence and the purification tag was removed; iii) for the
ternary complex supplemented with the disordered bind-
ing loop, PDB entry 2MSR was used. The structures were
energy minimized by the DMD [51] protocol of Chiron
(http://troll.med.unc.edu/chiron) [52]. Briefly, a short
simulation (1,000 time unit/steps) using a high heat ex-
change factor (HEX = 10) at a high temperature (0.7
temperature unit) was performed followed with a short
simulation with a low heat exchange factor (HEX = 0.1) at
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atoms were restrained. In all DMD simulations, including
those combined with replica exchange, a united-atom rep-
resentation is used to model proteins, in which all heavy
atoms and polar hydrogen atoms of each amino acid are
included [51, 53]. The solvent is implicitly modeled
employing the Lazaridis-Karplus solvation model [54].
Long range electrostatic interactions are also implemented
[51]. The πDMD software employed for simulations was
kindly provided by Molecules in Action, LLC (http://
www.moleculesinaction.com).
Replica exchange DMD (RX-DMD) simulations [53]
were performed with 8 replicas at temperatures 0.5497,
0.5624, 0.5753, 0.5886, 0.6022, 0.6161, 0.6303, and 0.6448
temperature unit, for 4,000,000 time units. One frame
(conformation) was generated every 200 time units.
Anderson’s thermostat was used and the heat exchange
factor was set to 0.1. At the end of a simulation, the
frames from every trajectory were grouped by temperature
for analysis. These simulations were run on the HPC of
the Institute of Enzymology (RCNS, HAS, Hungary, sup-
ported by the Momentum Program of HAS).
Ψ and Φ torsion angles were determined by DSSP [55]
for every structure at every temperature. The occurrence
of torsion angles characteristic of α-helices was counted
for every amino acid position and was divided by the total
number of the structures (10,000). To see if the α-helical
torsion angles arise at the level of individual amino acids
or continuous helices are formed, the helical content for
each frame was plotted along the amino acid sequence.
All calculations and plotting were done in R [56].
Reviewers’ comments
Arne Elofsson (Stockholm University)
In the paper the authors highlights the obvious fact that
proteins in histone lysine methylation are disordered.
This fact is readily available to anyone through for in-
stance uniprot annotations.
Authors’ response: Thank you for your work and your
suggestions that helped to improve the scientific quality
of our manuscript. Our aim was to draw attention to the
fact that although the information is indeed available,
yet no, or very few experimental works are aimed at the
study of these regions. In most papers published about
SET domain proteins the regions outside the SET domain
are completely neglected.
The paper lacks statistical analysis.
Authors’ response: We performed statistical analysis of
the disorder tendency of the different histone modifying
enzyme families and also the frequency of the predicted
ELM motifs compared to a randomized sequence dataset.
Additional statistical analyses are included in the revised
version of the manuscript along with the statistics of the
new results.Expressions such as “some, or many of the ELMs
found in this study may participate in the interactions of
HKMTs” needs to be statistically analysed. Is this an
overrepresentation or not.
Authors’ response: The original sentence begins with
“Our suggestion is…”, which is meant to show that this
was not, and without experimental proof, can not be a
definitive statement. We have shown that the predicted
ELMs are statistically overrepresented in HKMTs com-
pared to the random expectation. We complemented our
studies with a statistical analysis of ELMs that partici-
pate in protein-protein interactions and found that they
occur at a higher frequency than in the randomized se-
quence set; the results are included in the revised manu-
script. It needs to be emphasized though that this
statistical enrichment needs experimental verification, as
stated in the text.
Also the paper is full of statements like “Recognizing the
importance of protein disorder in the epigenetic regula-
tion is crucial for a deeper understanding that may bring
further development of this field.” which does not really
provide any novel insights but is more off an argument.
Authors’ response: The arguments are involved in the
text to further highlight the need for experimental studies
aimed at the regions of HKMTs aside from their globular
domains. Since these regions are almost completely
neglected in the structural and functional studies regard-
ing these proteins, it is difficult to provide more than ar-
guments at this point. However, we changed the wording
to be less dramatic.
It needs to at least be supported by a T-test showing
that epigenetic regulation is more common in disor-
dered regions than in ordered regions.
Authors’ response: The involvement of disordered pro-
teins/regions in chromatin remodelling and consequently
the epigenetic regulation has been analyzed by Sandhu
[9] who concluded that most chromatin-related proteins
contain long intrinsically disordered region. Our statis-
tical analysis showed that not all histone modifying en-
zyme families contain equal levels of intrinsic disorder
and that histone lysine methyltransferases and histone
acetyltransferases have significantly higher disorder level
than the other histone modifying enzymes. In the lack of
direct evidence of the enrichment of protein disorder in
epigenetic regulation, more profound analysis can not be
performed at the moment.
Finally, the obvious fact that the proteins contain
many Poly-Gln stretches (and many other interesting
features) is not discussed at all. What is their role ? How
is the charge important for binding?
Authors’ response: We included an analysis of single
amino acid repeat regions in the HKMTs in the manu-
script texts. However, since no available studies aimed to
uncover the role of these regions, we can only speculate
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vised text.
Finally the evolutionary analysis is very limited (not a
single multiple sequence alignment or tree is presented).
Authors’ response: Multiple sequence alignment was per-
formed for the DISCONS analysis and ANCHOR site con-
servation analysis and the results are available at this link
"github.com/lazartomi/HKMT_2016_raw". Because the
detailed evolutionary analysis of the HKMTs was not an
aim of our study and can be readily found in the literature
and also because of the limitations of the Discovery Notes
format, we did not see it necessary to present the alignment
as a main figure.
Therefore, I would suggest the authors to at the bare
minimum do
(1)a statistical analysis for all statements
Authors’ response: We have complemented the
statistical analysis with analysing the frequency of
ELMs participating in protein-protein interactions
and the predicted ANCHOR sites and included the
results in the manuscript text.
(2)provide an analysis of the sequences in more details
Authors’ response: We performed SEG analysis and
the results are included and discussed in the
manuscript. Further, we now speculate about the
possible role of highly repetitive, low-complexity
regions.
(3)provide a comparative genomics analysis
Authors’ response: We added an evolutionary
analysis of the protein length and gene number of
histone modifying enzyme families to the manuscript.
Our results show that while the number of HKMTs
does not differ significantly from most of the other
histone modifying enzymes, they are generally longer
in most of the evolutionary categories studied.
Piotr Zielenkiewicz (Institute of Biochemistry and
Biophysics, Polish Academy of Sciences)
Based on a limited number of experimental facts, the
Authors analyse the structural diversity of human histone
lysine methyltransferases. This analysis leads them to a
conclusion that disordered regions contain conserved
binding sites and may play a role in epigenetic regulation.
The paper is speculative, but based on solid knowledge
and sound bioinformatics analysis. In my opinion the final
hypothesis makes the manuscript worth publication.
I believe some recommendations to wet lab colleagues
will add value to the MS and I believe the Authors can
make such recommendations easily based on their ana-
lysis (and MD simulations?).
Authors’ response: Thank you for your review and posi-
tive comments. We have included the suggested recom-
mendations in the manuscript text.Additional files
Additional file 1: Figure S1. Long intrinsic disorder in histone
modifying protein families. (A) Number of amino acids in disordered
regions longer than 80 aa. (B) Distribution of disordered region length.
Dark gray: histone lysine methyltransferases, vertical dashes: histone
arginine methyltransferases, light gray: histone acetyltransferases, dots:
histone deacetylases, gray: histone demethylases, horizontal dashes:
UniProt average. (C) Frequency of disordered and low complexity
regions. Dark grey: low complexity regions, white: low complexity and
disordered regions, horizontal dashes: disordered regions. Differences
significant at 0.0001 ≤ p are marked with asterisk. (JPG 252 kb)
Additional file 2: Figure S2. Protein length and number in histone
modifying enzyme families. (A) Length of proteins in different histone
modifying enzyme families (B) Number of proteins in histone modifying
enzyme families. Dark gray: histone lysine methyltransferases, vertical
dashes: histone arginine methyltransferases, light gray: histone
acetyltransferases, dots: histone deacetylases, gray: histone demethylases.
Differences compared to HKMTs that are significant at 0.0001 ≤ p are
marked with asterisk. (PNG 108 kb)
Additional file 3: Table S1. Sequence and disorder conservation of six
human HKMTs and CBP and BRCA1 based on the multiple sequence
alignment of vertebrate orthologs. (DOCX 55 kb)
Additional file 4: Table S2. Human HKMTs with disorder rate (IUPred)
higher than 50 %. Disorder %: the total proportion of amino acids with
an IUPred score above 0.5. Longest IDR: the longest region with all amino
acids having IUPred score above 0.5. Function: catalytic activities of the
HKMTs. ELM motifs: Eukaryotic Linear Motifs collected from the ELM
database. Experimentally verified motifs are typed with normal characters
and predicted (e < 0.0001) with italic. Amino acid repeats: single amino acid
repeat regions determined in the SEG analysis. (DOCX 95 kb)
Additional file 5: Movie 1. Molecular dynamics simulation of the LEDGF/
p75-menin interaction. Cyan: LEDGF/p75, green: menin (MOV 13166 kb)
Additional file 6: Movie 2. Molecular dynamics simulation of the
MLL1-LEDGF/p75-menin interaction based on PDB 3U88. Salmon: MLL1,
cyan: LEDGF/p75, green: menin. Sidechains of MLL1 F148 and F151 are
red. (MOV 7391 kb)
Additional file 7: Movie 3. Molecular dynamics simulation of the
MLL1-LEDGF/p75-menin interaction based on PDB 2MSR. Salmon: MLL1,
cyan: LEDGF/p75, green: menin. Sidechains of MLL1 F148 and F151 are
red. (MOV 12102 kb)Abbreviations
aa, amino acid; CBP, CREB-binding protein; consANCHOR, Conserved
ANCHOR; DOT, disruptor of telomeric silencing; ELM, eukaryotic linear motif;
HAT, Histone acetyltransferase; HEX, heat exchange factor; HKMT, histone
lysine methyltransferase; HRMT, histone arginine methyltransferase; IDP,
intrinsically disordered protein; IDR, intrinsically disordered region; LEDGF,
lens epithelium-derived growth factor; MLL, mixed lineage leukemia; MSA,
multiple sequence alignment; NSD1, Nuclear receptor-binding SET Domain-
containing protein 1; PTM, posttranslational modifications; RX-DMD, replica
exchange - discrete molecular dynamics; SET, suppressor of variegation 3–9,
Enhancer of zeste and Trithorax; SNP, single-nucleotide polymorphism; TAD,
Transactivation domain; Ub, ubiquitin.
Acknowledgements
Not applicable.Funding
The authors receive funding from the Odysseus grant G.0029.12 from
Research Foundation Flanders (Peter Tompa), the Korean-Hungarian Joint
Laboratory grant from Korea Research Council of Fundamental Science and
Technology, the OTKA grant PD-OTKA 108772 (Eva Schad), the Bolyai János
Research Scholarship of the Hungarian Academy of Sciences and the
MedInProt Protein Science Research Synergy Program (Agnes Tantos).
Lazar et al. Biology Direct  (2016) 11:30 Page 9 of 10Availability of data and materials
Raw data used for the analyses are accessible here: github.com/lazartomi/
HKMT_2016_raw
Authors’ contributions
TL: Performed data collection, literature mining, major bioinformatics tasks
(Fig. 1, Additional file 3: Tables S1 and Additional file 4: Table S2).
Participated in the writing of the manuscript. ES: Performed disorder
predictions and statistical analysis, prepared Additional file 1: Figure S1. BSz:
Collected data from cancer related databases and participated in writing the
manuscript. TH: Performed the molecular dynamics simulations (Fig. 2 and
Additional file 5: Movie 1, Additional file 6: Movie 2 and Additional file 7:
Movie 3). MA: Collected sequence-specific interaction data of the HKMTs for
Fig. 1, participated in the writing of the manuscript PT: Assisted the writing
of the manuscript with scientific insight and advice, participated in the
writing process. AT: Conceived of the study, wrote the main manuscript text,
directed the work. All authors read and approved the final manuscript.
Authors’ information
Tamas Lazar: Institute of Enzymology, Research Centre for Natural Sciences,
Hungarian Academy of Sciences, Magyar tudósok körútja 2, 1117 Budapest,
Hungary; Pázmány Péter Catholic University, Faculty of Information
Technology and Bionics, Práter utca 50/a, 1083 Budapest, Hungary.
e-mail: lazar.tamas@ttk.mta.hu
Eva Schad: Institute of Enzymology, Research Centre for Natural Sciences,
Hungarian Academy of Sciences, Magyar tudósok körútja 2, 1117 Budapest,
Hungary. e-mail: schad.eva@ttk.mta.hu
Beata Szabo: Institute of Enzymology, Research Centre for Natural Sciences,
Hungarian Academy of Sciences, Magyar tudósok körútja 2, 1117 Budapest,
Hungary. e-mail: szabo.beata@ttk.mta.hu
Tamas Horvath: Institute of Enzymology, Research Centre for Natural
Sciences, Hungarian Academy of Sciences, Magyar tudósok körútja 2, 1117
Budapest, Hungary. e-mail: horvath.tamas@ttk.mta.hu
Attila Meszaros: Institute of Enzymology, Research Centre for Natural
Sciences, Hungarian Academy of Sciences, Magyar tudósok körútja 2, 1117
Budapest, Hungary. e-mail: meszaros.attila@ttk.mta.hu
Peter Tompa: Institute of Enzymology, Research Centre for Natural Sciences,
Hungarian Academy of Sciences, Magyar tudósok körútja 2, 1117 Budapest,
Hungary; VIB Structural Biology Research Center (SBRC), Pleinlaan 2, 1050
Brussels, Belgium; Vrije Universiteit Brussel, Pleinlaan 2, 1050 Brussels,
Belgium. e-mail: ptompa@vub.ac.be
Agnes Tantos: Institute of Enzymology, Research Centre for Natural Sciences,
Hungarian Academy of Sciences, Magyar tudósok körútja 2, 1117 Budapest,
Hungary. e-mail: tantos.agnes@ttk.mta.hu
Competing interests
The authors declare that they have no competing interests.
Consent for publication
All authors read and approved the final manuscript.
Ethical approval and consent to participate
Not applicable.
Author details
1Institute of Enzymology, Research Centre for Natural Sciences, Hungarian
Academy of Sciences, Magyar tudósok körútja 2, 1117 Budapest, Hungary.
2Pázmány Péter Catholic University, Faculty of Information Technology and
Bionics, Práter utca 50/a, 1083 Budapest, Hungary. 3VIB Structural Biology
Research Center (SBRC), Pleinlaan 2, 1050 Brussels, Belgium. 4Vrije Universiteit
Brussel, Pleinlaan 2, 1050 Brussels, Belgium.
Received: 2 March 2016 Accepted: 17 May 2016
References
1. Copeland RA. Molecular Pathways: Protein Methyltransferases in Cancer. Clin
Cancer Res. 2013;19:6344–50.
2. Herz H-M, Garruss A, Shilatifard A. SET for life: biochemical activities and
biological functions of SET domain-containing proteins. Trends Biochem Sci.
2013;38:621–39.3. Feng Q, Qin F, Hengbin W, Ng HH, Hediye E-B, Paul T, et al. Methylation of
H3-Lysine 79 Is Mediated by a New Family of HMTases without a SET
Domain. Curr Biol. 2002;12:1052–8.
4. Rao RC, Dou Y. Hijacked in cancer: the KMT2 (MLL) family of methyltransferases.
Nat Rev Cancer. 2015;15:334–46.
5. McGrath J, Trojer P. Targeting histone lysine methylation in cancer.
Pharmacol Ther. 2015;150:1–22.
6. Tompa P. Structure and Function of Intrinsically Disordered Proteins. Boca
Raton, FL, USA: CRC Press; 2009.
7. Tantos A, Kalmar L, Tompa P. The role of structural disorder in cell cycle
regulation, related clinical proteomics, disease development and drug
targeting. Expert Rev Proteomics. 2015;12:221–33.
8. Wright PE, Dyson HJ. Intrinsically disordered proteins in cellular signalling
and regulation. Nat Rev Mol Cell Biol. 2015;16:18–29.
9. Sandhu KS. Intrinsic disorder explains diverse nuclear roles of chromatin
remodeling proteins. J Mol Recognit. 2009;22:1–8.
10. Schlessinger A, Avner S, Christian S, Esmeralda V, Markus S, Marco P, et al.
Protein disorder—a breakthrough invention of evolution? Curr Opin Struct
Biol. 2011;21:412–8.
11. Schad E, Tompa P, Hegyi H. The relationship between proteome size,
structural disorder and organism complexity. Genome Biol. 2011;12:R120.
12. Varadi M, Guharoy M, Zsolyomi F, Tompa P. DisCons: a novel tool to
quantify and classify evolutionary conservation of intrinsic protein disorder.
BMC Bioinformatics. 2015;16:153.
13. Chen JW, Pedro R, Uversky VN, Keith DA. Conservation of Intrinsic Disorder
in Protein Domains and Families: I. A Database of Conserved Predicted
Disordered Regions. J Proteome Res. 2006;5:879–87.
14. Capra JA, Singh M. Predicting functionally important residues from
sequence conservation. Bioinformatics. 2007;23:1875–82.
15. Ganguly D, Zhang W, Chen J. Synergistic folding of two intrinsically
disordered proteins: searching for conformational selection. Mol Biosyst.
2012;8:198–209.
16. Wootton JC. Non-globular domains in protein sequences: automated
segmentation using complexity measures. Comput Chem. 1994;18:269–85.
17. Coletta A, Alain C, Pinney JW, David S, James M, Pettifer SR, et al. Low-
complexity regions within protein sequences have position-dependent
roles. BMC Syst Biol. 2010;4:43.
18. Weber JJ, Sowa AS, Binder T, Hübener J. From pathways to targets:
understanding the mechanisms behind polyglutamine disease. Biomed Res
Int. 2014;2014:701758.
19. Lupas A, Van Dyke M, Stock J. Predicting coiled coils from protein
sequences. Science. 1991;252:1162–4.
20. Schaefer MH, Wanker EE, Andrade-Navarro MA. Evolution and function of
CAG/polyglutamine repeats in protein-protein interaction networks. Nucleic
Acids Res. 2012;40:4273–87.
21. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human
disease. Annu Rev Biochem. 2006;75:333–66.
22. Dinkel H, Van Roey K, Michael S, Davey NE, Weatheritt RJ, Born D, et al. The
eukaryotic linear motif resource ELM: 10 years and counting. Nucleic Acids
Res. 2014;42:D259–66.
23. Zhang P, Lee H, Brunzelle JS, Couture J-F. The plasticity of WDR5
peptide-binding cleft enables the binding of the SET1 family of histone
methyltransferases. Nucleic Acids Res. 2012;40:4237–46.
24. Tesina P, Čermáková K, Hořejší M, Procházková K, Fábry M, Sharma S, et al.
Multiple cellular proteins interact with LEDGF/p75 through a conserved
unstructured consensus motif. Nat Commun. 2015;6:7968.
25. Dosztanyi Z, Meszaros B, Simon I. ANCHOR: web server for predicting protein
binding regions in disordered proteins. Bioinformatics. 2009;25:2745–6.
26. Kuntimaddi A, Achille NJ, Thorpe J, Lokken AA, Singh R, Hemenway CS,
et al. Degree of recruitment of DOT1L to MLL-AF9 defines level of H3K79
Di- and tri-methylation on target genes and transformation potential.
Cell Rep. 2015;11:808–20.
27. Meyer C, Hofmann J, Burmeister T, Gröger D, Park TS, Emerenciano M,
et al. The MLL recombinome of acute leukemias in 2013. Leukemia.
2013;27:2165–76.
28. McGinty RK, Kim J, Chatterjee C, Roeder RG, Muir TW. Chemically
ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal
methylation. Nature. 2008;453:812–6.
29. Oh S, Jeong K, Kim H, Kwon CS, Lee D. A lysine-rich region in Dot1p is
crucial for direct interaction with H2B ubiquitylation and high level
methylation of H3K79. Biochem Biophys Res Commun. 2010;399:512–7.
Lazar et al. Biology Direct  (2016) 11:30 Page 10 of 1030. Nielsen AL, Jørgensen P, Lerouge T, Cerviño M, Chambon P, Losson R.
Nizp1, a novel multitype zinc finger protein that interacts with the NSD1
histone lysine methyltransferase through a unique C2HR motif. Mol Cell
Biol. 2004;24:5184–96.
31. Ernst P, Wang J, Huang M, Goodman RH, Korsmeyer SJ. MLL and CREB bind
cooperatively to the nuclear coactivator CREB-binding protein. Mol Cell Biol.
2001;21:2249–58.
32. De Guzman RN, Goto NK, Dyson HJ, Wright PE. Structural basis for
cooperative transcription factor binding to the CBP coactivator. J Mol Biol.
2006;355:1005–13.
33. Terranova R, Agherbi H, Boned A, Meresse S, Djabali M. Histone and DNA
methylation defects at Hox genes in mice expressing a SET domain-
truncated form of Mll. Proc Natl Acad Sci U S A. 2006;103:6629–34.
34. de Boer J, Walf-Vorderwülbecke V, Williams O. In focus: MLL-rearranged
leukemia. Leukemia. 2013;27:1224–8.
35. Hegyi H, Buday L, Tompa P. Intrinsic structural disorder confers cellular
viability on oncogenic fusion proteins. PLoS Comput Biol. 2009;5:e1000552.
36. Kalmar L, Acs V, Silhavy D, Tompa P. Long-range interactions in nonsense-
mediated mRNA decay are mediated by intrinsically disordered protein
regions. J Mol Biol. 2012;424:125–31.
37. Tompa P. Multisteric regulation by structural disorder in modular
signaling proteins: an extension of the concept of allostery. Chem Rev.
2014;114:6715–32.
38. Arai M, Sugase K, Dyson HJ, Wright PE. Conformational propensities of
intrinsically disordered proteins influence the mechanism of binding and
folding. Proc Natl Acad Sci U S A. 2015;112:9614–9.
39. Yokoyama A, Akihiko Y, Cleary ML. Menin Critically Links MLL Proteins with
LEDGF on Cancer-Associated Target Genes. Cancer Cell. 2008;14:36–46.
40. Huang J, Gurung B, Wan B, Matkar S, Veniaminova NA, Wan K, et al. The
same pocket in menin binds both MLL and JUND but has opposite effects
on transcription. Nature. 2012;482:542–6.
41. Cermáková K, Tesina P, Demeulemeester J, El Ashkar S, Méreau H, Schwaller
J, et al. Validation and structural characterization of the LEDGF/p75-MLL
interface as a new target for the treatment of MLL-dependent leukemia.
Cancer Res. 2014;74:5139–51.
42. Murai MJ, Pollock J, He S, Miao H, Purohit T, Yokom A, et al. The same site
on the integrase-binding domain of lens epithelium-derived growth factor
is a therapeutic target for MLL leukemia and HIV. Blood. 2014;124:3730–7.
43. Goyal S, Gupta G, Qin H, Upadya MH, Tan YJ, Chow VTK, et al. VAPC, an
human endogenous inhibitor for hepatitis C virus (HCV) infection, is
intrinsically unstructured but forms a “fuzzy complex” with HCV NS5B.
PLoS One. 2012;7:e40341.
44. Dosztanyi Z, Csizmok V, Tompa P, Simon I. IUPred: web server for the
prediction of intrinsically unstructured regions of proteins based on
estimated energy content. Bioinformatics. 2005;21:3433–4.
45. Potenza E, Di Domenico T, Walsh I, Tosatto SCE. MobiDB 2.0: an improved
database of intrinsically disordered and mobile proteins. Nucleic Acids Res.
2015;43:D315–20.
46. Oates ME, Romero P, Ishida T, Ghalwash M, Mizianty MJ, Xue B, et al. D2P2:
database of disordered protein predictions. Nucleic Acids Res.
2013;41:D508–16.
47. Stark C, Breitkreutz B-J, Reguly T, Boucher L, Breitkreutz A, Tyers M.
BioGRID: a general repository for interaction datasets. Nucleic Acids Res.
2006;34:D535–9.
48. Wu T-J, Shamsaddini A, Pan Y, Smith K, Crichton DJ, Simonyan V, et al. A
framework for organizing cancer-related variations from existing databases,
publications and NGS data using a High-performance Integrated Virtual
Environment (HIVE). Database. 2014;2014:bau022.
49. Forbes SA, Beare D, Gunasekaran P, Leung K, Bindal N, Boutselakis H, et al.
COSMIC: exploring the world’s knowledge of somatic mutations in human
cancer. Nucleic Acids Res. 2015;43:D805–11.
50. Valdar WSJ. Scoring residue conservation. Proteins: Struct Funct Genet. 2002;
48:227–41.
51. Shirvanyants D, Ding F, Tsao D, Ramachandran S, Dokholyan NV. Discrete
molecular dynamics: an efficient and versatile simulation method for fine
protein characterization. J Phys Chem B. 2012;116:8375–82.
52. Ramachandran S, Kota P, Ding F, Dokholyan NV. Automated minimization of
steric clashes in protein structures. Proteins. 2011;79:261–70.
53. Ding F, Tsao D, Nie H, Dokholyan NV. Ab initio folding of proteins with
all-atom discrete molecular dynamics. Structure. 2008;16:1010–8.54. Lazaridis T, Karplus M. Effective energy function for proteins in solution.
Proteins. 1999;35:133–52.
55. Kabsch W, Sander C. Dictionary of protein secondary structure: pattern
recognition of hydrogen-bonded and geometrical features. Biopolymers.
1983;22:2577–637.
56. R Core Team. R: A Language and Environment for Statistical Computing. R
Foundation for Statistical Computing; 2015; Available: https://www.R-project.org•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
